NICE: faster access to modern treatments? Analysis of guidance on health technologies

doi:10.1136/bmj.323.7324.1300

BMJ 2001;323:1300-1303 ( 1 December )

Education and debate

NICE: faster access to modern treatments? Analysis of guidance on health technologies

James Raftery, professor of health economics.

Health Services Management Centre, School of Public Policy, University of Birmingham, Birmingham B15 2RT

J.P.Raftery@bham.ac.uk

The first 150 words of the full text of this article appear below.

	Introduction

The National Institute for Clinical Excellence (NICE) was set up as a special health authority for England and Wales in 1999.Its role is to provide patients, health professionals, and thepublic with authoritative, robust, and reliable guidance on current"best practice." It has three main functions: to appraise newtechnologies, to produce or approve guidelines, and to encourageimprovement in quality. NICE was first announced in the new Labourgovernment's white paper The New NHS.¹ As a special healthauthority it is part of the Department of Health. NICE marks aninnovation internationally in that while some other countrieshave bodies to provide advice on which new health technologiesto use, NICE is the first national body with power to issue guidancecovering the full range of health technologies.² Guidance fromNICE applies to the NHS in the same way as guidance from otherparts of the Department . . . [Full text of this article]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati What's this?

Relevant Articles

Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study: S C Griffin, J A Barber, A Manca, M J Sculpher, S G Thompson, M J Buxton, and H Hemingway
BMJ 2007 334: 624. [Abstract] [Full Text] [PDF]

Acupuncture in mainstream health care: David Wonderling
BMJ 2006 333: 611-612. [Extract] [Full Text] [PDF]

Review of NICE's recommendations, 1999-2005: James Raftery
BMJ 2006 332: 1266-1268. [Full Text] [PDF]

Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT): UKATT Research Team
BMJ 2005 331: 544. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

O'reilly, J., Lowson, K., Green, J., Young, J. B., Forster, A. (2008). Post-acute care for older people in community hospitals--a cost-effectiveness analysis within a multi-centre randomised controlled trial. Age Ageing 37: 513-520 [Abstract] [Full text]
Bravo Vergel, Y., Sculpher, M. (2008). Quality-adjusted life years. PN 8: 175-182 [Abstract] [Full text]
Campion, J., Checinski, K., Nurse, J. (2008). Review of smoking cessation treatments for people with mental illness. Adv. Psychiatr. Treat. 14: 208-216 [Abstract] [Full text]
Elahi, M. M, Khan, J. S (2008). Coronary Heart Disease Service Framework for Revascularization in Pakistan. Asian Cardiovasc. Thorac. Ann. 16: 81-85 [Abstract] [Full text]
Lewis, M., James, M., Stokes, E., Hill, J., Sim, J., Hay, E., Dziedzic, K. (2007). An economic evaluation of three physiotherapy treatments for non-specific neck disorders alongside a randomized trial. Rheumatology (Oxford) 46: 1701-1708 [Abstract] [Full text]
Bravo Vergel, Y., Hawkins, N. S., Claxton, K., Asseburg, C., Palmer, S., Woolacott, N., Bruce, I. N., Sculpher, M. J. (2007). The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis. Rheumatology (Oxford) 46: 1729-1735 [Abstract] [Full text]
Bravo Vergel, Y., Palmer, S., Asseburg, C., Fenwick, E., de Belder, M., Abrams, K., Sculpher, M. (2007). Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis. Heart 93: 1238-1243 [Abstract] [Full text]
Briggs, A., Mihaylova, B., Sculpher, M., Hall, A., Wolstenholme, J., Simoons, M., Deckers, J., Ferrari, R., Remme, W. J, Bertrand, M., Fox, K., on behalf of the EUROPA Trial Investigators, (2007). Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study. Heart 93: 1081-1086 [Abstract] [Full text]
Walker, S., Palmer, S., Sculpher, M. (2007). The role of NICE technology appraisal in NHS rationing. Br Med Bull 0: ldm007v1-14 [Abstract] [Full text]
Griffin, S C, Barber, J A, Manca, A, Sculpher, M J, Thompson, S G, Buxton, M J, Hemingway, H (2007). Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study. BMJ 334: 624-624 [Abstract] [Full text]
Wright, J., Bibby, J., Eastham, J., Harrison, S., McGeorge, M., Patterson, C., Price, N., Russell, D., Russell, I., Small, N., Walsh, M., Young, J. (2007). Multifaceted implementation of stroke prevention guidelines in primary care: cluster-randomised evaluation of clinical and cost effectiveness. Qual Saf Health Care 16: 51-59 [Abstract] [Full text]
Dolan, P., Peasgood, T. (2007). Estimating the Economic and Social Costs of the Fear of Crime. Br J Criminol 47: 121-132 [Abstract] [Full text]
Canter, P. H., Coon, J. T., Ernst, E. (2006). Cost-Effectiveness of Complementary Therapies in the United Kingdom--A Systematic Review{dagger}. Evid Based Complement Alternat Med 3: 425-432 [Abstract] [Full text]
Wonderling, D. (2006). Acupuncture in mainstream health care. BMJ 333: 611-612 [Full text]
Grieve, R, Roberts, J, Wright, M, Sweeting, M, DeAngelis, D, Rosenberg, W, Bassendine, M, Main, J, Thomas, H (2006). Cost effectiveness of interferon {alpha} or peginterferon {alpha} with ribavirin for histologically mild chronic hepatitis C. Gut 55: 1332-1338 [Abstract] [Full text]
Witt, C. M., Jena, S., Selim, D., Brinkhaus, B., Reinhold, T., Wruck, K., Liecker, B., Linde, K., Wegscheider, K., Willich, S. N. (2006). Pragmatic Randomized Trial Evaluating the Clinical and Economic Effectiveness of Acupuncture for Chronic Low Back Pain. Am J Epidemiol 164: 487-496 [Abstract] [Full text]
Raftery, J. (2006). Review of NICE's recommendations, 1999-2005.. BMJ 332: 1266-1268 [Full text]
Petrou, S., Bischof, M., Bennett, C., Elbourne, D., Field, D., McNally, H. (2006). Cost-Effectiveness of Neonatal Extracorporeal Membrane Oxygenation Based on 7-Year Results From the United Kingdom Collaborative ECMO Trial. Pediatrics 117: 1640-1649 [Abstract] [Full text]
Singaroyan, R., Seed, C. A., Egdell, R. M. (2006). Is a target culture in health care always compatible with efficient use of resources? A cost-effectiveness analysis of an intervention to achieve thrombolysis targets. J Public Health (Oxf) 28: 31-34 [Abstract] [Full text]
Neyt, M., Albrecht, J., Cocquyt, V. (2006). An economic evaluation of Herceptin(R) in adjuvant setting: the Breast Cancer International Research Group 006 trial. Ann Oncol 17: 381-390 [Abstract] [Full text]
Chase, D, Roderick, P, Cooper, K, Davies, R, Quinn, T, Raftery, J (2006). Using simulation to estimate the cost effectiveness of improving ambulance and thrombolysis response times after myocardial infarction. Emerg. Med. J. 23: 67-72 [Abstract] [Full text]
PARROTT, S., GODFREY, C., HEATHER, N., CLARK, J., RYAN, T. (2006). COST AND OUTCOME ANALYSIS OF TWO ALCOHOL DETOXIFICATION SERVICES. Alcohol Alcohol 41: 84-91 [Abstract] [Full text]
Sampson, F C, Goodacre, S, Kelly, A-M, Kerr, D (2005). How is deep vein thrombosis diagnosed and managed in UK and Australian emergency departments?. Emerg. Med. J. 22: 780-782 [Abstract] [Full text]
UKATT Research Team, (2005). Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT). BMJ 331: 544- [Abstract] [Full text]
Bansback, N J, Brennan, A, Ghatnekar, O (2005). Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden. Ann Rheum Dis 64: 995-1002 [Abstract] [Full text]
Goodacre, S, Dixon, S (2005). Is a chest pain observation unit likely to be cost effective at my hospital? Extrapolation of data from a randomised controlled trial. Emerg. Med. J. 22: 418-422 [Abstract] [Full text]
Raftery, J. P, Yao, G. L, Murchie, P., Campbell, N. C, Ritchie, L. D (2005). Cost effectiveness of nurse led secondary prevention clinics for coronary heart disease in primary care: follow up of a randomised controlled trial. BMJ 330: 707- [Abstract] [Full text]
Harvey, N., Cooper, C. (2005). Physiotherapy for neck and back pain. BMJ 330: 53-54 [Full text]
Miners, A H, Garau, M., Fidan, D., Fischer, A J (2005). Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study. BMJ 330: 65- [Abstract] [Full text]
UK BEAM Trial Team, (2004). United Kingdom back pain exercise and manipulation (UK BEAM) randomised trial: cost effectiveness of physical treatments for back pain in primary care. BMJ 329: 1381- [Abstract] [Full text]
Munro, J. F, Nicholl, J. P, Brazier, J. E, Davey, R., Cochrane, T. (2004). Cost effectiveness of a community based exercise programme in over 65 year olds: cluster randomised trial. J. Epidemiol. Community Health 58: 1004-1010 [Abstract] [Full text]
Williams, N. H, Edwards, R. T, Linck, P., Muntz, R., Hibbs, R., Wilkinson, C., Russell, I., Russell, D., Hounsome, B. (2004). Cost-utility analysis of osteopathy in primary care: results from a pragmatic randomized controlled trial. Fam Pract 21: 643-650 [Abstract] [Full text]
Taylor, R S, Drummond, M F, Salkeld, G, Sullivan, S D (2004). Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. BMJ 329: 972-975 [Full text]
Buxton, M.J., Sullivan, S.D., Andersson, L.F., Lamm, C.J., Liljas, B., Busse, W.W, Pedersen, S., Weiss, K.B. (2004). Country-specific cost-effectiveness of early intervention with budesonide in mild asthma. Eur Respir J 24: 568-574 [Abstract] [Full text]
Petrou, S, Edwards, L (2004). Cost effectiveness analysis of neonatal extracorporeal membrane oxygenation based on four year results from the UK Collaborative ECMO Trial. Arch. Dis. Child. Fetal Neonatal Ed. 89: F263-F268 [Abstract] [Full text]
Parrott, S., Godfrey, C. (2004). Economics of smoking cessation. BMJ 328: 947-949 [Full text]
Wonderling, D., Vickers, A. J, Grieve, R., McCarney, R. (2004). Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care. BMJ 328: 747- [Abstract] [Full text]
Goodacre, S., Nicholl, J., Dixon, S., Cross, E., Angelini, K., Arnold, J., Revill, S., Locker, T., Capewell, S. J, Quinney, D., Campbell, S., Morris, F. (2004). Randomised controlled trial and economic evaluation of a chest pain observation unit compared with routine care. BMJ 328: 254- [Abstract] [Full text]
Sculpher, M., Manca, A., Abbott, J., Fountain, J., Mason, S., Garry, R. (2004). Cost effectiveness analysis of laparoscopic hysterectomy compared with standard hysterectomy: results from a randomised trial. BMJ 328: 134- [Abstract] [Full text]
Renehan, A. G, O'Dwyer, S. T, Whynes, D. K (2004). Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer. BMJ 328: 81- [Abstract] [Full text]
Holloway, R., Dick, A. W. (2004). Editorial Comment--Stroke Cost-Effectiveness Research: Are Acceptability Curves Acceptable?. Stroke 35: 203-204 [Full text]
Patel, A., Knapp, M., Perez, I., Evans, A., Kalra, L. (2004). Alternative Strategies for Stroke Care: Cost-Effectiveness and Cost-Utility Analyses From a Prospective Randomized Controlled Trial. Stroke 35: 196-203 [Abstract] [Full text]
Mossialos, E., McKee, M. (2003). Rationing treatment on the NHS--still a political issue. JRSM 96: 372-373 [Full text]
Multicentre Aneurysm Screening Study Group, (2002). Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomised controlled trial. BMJ 325: 1135-1135 [Abstract] [Full text]
Song, F., Raftery, J., Aveyard, P., Hyde, C., Barton, P., Woolacott, N. (2002). Cost-Effectiveness of Pharmacological Interventions for Smoking Cessation: a Literature Review and a Decision Analytic Analysis. Med Decis Making 22: S26-S37 [Abstract]